EASTLEIGH MEDICAL PRACTICE — All Prescriptions & Medications — Page 3
Practice Code: J82020 | EASTLEIGH, SO50 9AG
Showing results 101-150 of 572
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Diazepam | 312 | 6,698 | £148 | -37.4% ▼ |
| Mometasone furoate | 312 | 387 | £2.9K | -22.3% ▼ |
| Doxycycline hyclate | 310 | 5,241 | £500 | -39.5% ▼ |
| Olanzapine | 305 | 9,282 | £2.3K | -17.7% ▼ |
| Rosuvastatin calcium | 301 | 14.1K | £402 | -66.5% ▼ |
| Nifedipine | 286 | 23.4K | £3.7K | +52.6% ▲ |
| Betamethasone valerate | 284 | 26.5K | £1.3K | -26.2% ▼ |
| Dihydrocodeine tartrate | 281 | 27.0K | £1.9K | +43.8% ▲ |
| Finasteride | 280 | 13.4K | £454 | -57.2% ▼ |
| Hydrocortisone | 278 | 10.1K | £2.3K | -38.0% ▼ |
| Nitrofurantoin | 274 | 4,334 | £1.9K | -42.6% ▼ |
| Ezetimibe | 273 | 13.6K | £2.2K | -61.6% ▼ |
| 273 | 34.0K | £4.1K | +573.1% ▲ | |
| Insulin degludec | 270 | 1,762 | £21.1K | +145.7% ▲ |
| Estriol | 265 | 5,149 | £2.3K | +24.5% ▲ |
| Tiotropium bromide | 262 | 3,732 | £10.4K | -13.8% ▼ |
| 252 | 3,300 | £1.3K | +1.0% vs avg | |
| Ready to serve 1.5 kcal/ml milkshake (0913011) | 248 | 1.7M | £10.0K | +74.5% ▲ |
| Dorzolamide and timolol | 247 | 8,925 | £5.2K | +72.6% ▲ |
| Co-careldopa (Carbidopa/levodopa) | 246 | 38.8K | £2.4K | +8.9% ▲ |
| Flucloxacillin sodium | 234 | 8,209 | £449 | -48.0% ▼ |
| Codeine phosphate | 232 | 20.1K | £622 | -67.7% ▼ |
| Tapentadol | 229 | 11.6K | £8.1K | +456.3% ▲ |
| Loperamide hydrochloride | 223 | 15.8K | £388 | -4.2% ▼ |
| Tirzepatide | 222 | 383 | £35.8K | +14.3% ▲ |
| Mebeverine hydrochloride | 220 | 24.1K | £1.3K | -29.1% ▼ |
| Aripiprazole | 217 | 9,077 | £2.7K | -14.7% ▼ |
| Isosorbide mononitrate | 213 | 12.0K | £1.5K | -67.8% ▼ |
| Sacubitril/valsartan | 211 | 14.9K | £24.4K | -11.9% ▼ |
| Estradiol | 211 | 5,232 | £2.5K | -21.8% ▼ |
| Betahistine hydrochloride | 210 | 23.3K | £760 | -12.0% ▼ |
| Fluticasone furoate | 197 | 252 | £1.6K | +1.7% vs avg |
| Mesalazine (Systemic) | 196 | 28.8K | £13.8K | -18.2% ▼ |
| Co-dydramol (Dihydrocodeine/paracetamol) | 196 | 30.7K | £1.3K | +9.1% ▲ |
| Fluticasone propionate (Inhalation) | 194 | 327 | £7.5K | -49.9% ▼ |
| Mirabegron | 186 | 9,864 | £9.1K | -53.7% ▼ |
| Oxybutynin | 184 | 13.5K | £4.6K | -3.4% ▼ |
| Memantine hydrochloride | 182 | 5,610 | £636 | -44.9% ▼ |
| Letrozole | 181 | 6,087 | £551 | -3.1% ▼ |
| Umeclidinium bromide/vilanterol | 179 | 277 | £8.6K | -8.2% ▼ |
| Alfacalcidol | 179 | 9,380 | £1.6K | +44.7% ▲ |
| Quinine sulfate | 178 | 6,636 | £987 | -38.5% ▼ |
| Semaglutide | 178 | 4,686 | £25.4K | -26.1% ▼ |
| Tadalafil | 178 | 4,124 | £1.0K | +4.7% ▲ |
| Ferrous sulfate | 177 | 10.8K | £344 | -65.6% ▼ |
| Clobetasone butyrate | 177 | 9,215 | £1.8K | -13.3% ▼ |
| Diclofenac diethyl | 175 | 22.9K | £1.3K | -50.7% ▼ |
| Pravastatin sodium | 172 | 9,100 | £401 | -47.0% ▼ |
| 170 | 186 | £1.0K | -28.0% ▼ | |
| 161 | 63.4K | £1.2K | -39.0% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.